Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2000
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study GroupK Werther, I J Christensen, N Brünner, et al.
Experimental Cell Biology|January 1, 1986
Effect of melphalan on growth curves and cell cycle distribution of four human small cell carcinomas of the lung grown in nude miceS A Engelholm, M Spang-Thomsen, L L Vindeløv, et al.
Clinical & Experimental Metastasis|September 1, 1997
Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell linesC Gilles, M Polette, P Birembaut, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissueA N Pedersen, H T Mouridsen, D Y Tenney, et al.
Annals of the Rheumatic Diseases|July 27, 1999
Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritisO Slot, N Brünner, H Locht, et al.
The International Journal of Biological Markers|February 1, 2002
Soluble urokinase plasminogen activator receptor measurements: influence of sample handlingR Riisbro, I J Christensen, C Høgdall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosisH Pappot, D Francis, N Brünner, et al.
International Journal of Cancer|January 15, 1994
Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cellsP Coopman, M Garcia, N Brünner, et al.
Annals of Surgical Oncology|September 27, 2000
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study GroupH J Nielsen, I J Christensen, S Sørensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 2007
Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancerC Frederiksen, J Lykke, Ib J Christensen, et al.
Pageof 15